ID

38333

Beschrijving

A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2); ODM derived from: https://clinicaltrials.gov/show/NCT01740427

Link

https://clinicaltrials.gov/show/NCT01740427

Trefwoorden

Versies (1)
  1. 11-10-19 11-10-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

11 oktober 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Neoplasms NCT01740427

Engels

Eligibility Breast Neoplasms NCT01740427

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult women with locoregionally recurrent or metastatic disease not amenable to curative therapy.
Beschrijving

Adult | Gender | Recurrent disease Locoregional | Neoplasm Metastasis | Disease Inappropriate Curative treatment

Datatype

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0079399
UMLS CUI [3,1]
C0277556
UMLS CUI [3,2]
C1947913
UMLS CUI [4]
C0027627
UMLS CUI [5,1]
C0012634
UMLS CUI [5,2]
C1548788
UMLS CUI [5,3]
C1273390
confirmed diagnosis of er positive breast cancer
Beschrijving

Oestrogen receptor positive breast cancer

Datatype

boolean

Alias
UMLS CUI [1]
C2938924
no prior systemic anti-cancer therapy for advanced er+ disease.
Beschrijving

Cancer treatment Systemic Absent | Advanced disease Estrogen receptor positive

Datatype

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205373
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0679246
UMLS CUI [2,2]
C0279754
postmenopausal women
Beschrijving

Postmenopausal state

Datatype

boolean

Alias
UMLS CUI [1]
C0232970
measurable disease as per response evaluation criterion in solid tumors [recist] or bone-only disease
Beschrijving

Measurable Disease | Bone Disease only

Datatype

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2,1]
C0005940
UMLS CUI [2,2]
C0205171
eastern cooperative oncology group [ecog] 0-2
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
adequate organ and marrow function
Beschrijving

Organ function | Bone Marrow function

Datatype

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C0031843
patient must agree to provide tumor tissue
Beschrijving

Tumor tissue sample Provide

Datatype

boolean

Alias
UMLS CUI [1,1]
C0475358
UMLS CUI [1,2]
C1999230
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
confirmed diagnosis of her2 positive disease
Beschrijving

Disease HER2 Positive

Datatype

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C2348909
patients with advanced, symptomatic, visceral spread that are at risk of life threatening complication in the short term
Beschrijving

Spread Visceral Symptomatic Advanced | At risk Complications Life Threatening

Datatype

boolean

Alias
UMLS CUI [1,1]
C0332261
UMLS CUI [1,2]
C0442045
UMLS CUI [1,3]
C0231220
UMLS CUI [1,4]
C0205179
UMLS CUI [2,1]
C1444641
UMLS CUI [2,2]
C0009566
UMLS CUI [2,3]
C2826244
known uncontrolled or symptomatic cns metastases
Beschrijving

CNS metastases Uncontrolled | CNS metastases Symptomatic

Datatype

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0686377
UMLS CUI [2,2]
C0231220
prior (neo)adjuvant treatment with letrozole or anastrozole with dfi ≤ 12-months from completion of treatment.
Beschrijving

Adjuvant therapy Letrozole | Adjuvant therapy Anastrozole | Neoadjuvant Therapy Letrozole | Neoadjuvant Therapy Anastrozole | Treatment completed | Interval Disease Free

Datatype

boolean

Alias
UMLS CUI [1,1]
C0677850
UMLS CUI [1,2]
C0246421
UMLS CUI [2,1]
C0677850
UMLS CUI [2,2]
C0290883
UMLS CUI [3,1]
C0600558
UMLS CUI [3,2]
C0246421
UMLS CUI [4,1]
C0600558
UMLS CUI [4,2]
C0290883
UMLS CUI [5]
C0580352
UMLS CUI [6,1]
C1272706
UMLS CUI [6,2]
C0012634
UMLS CUI [6,3]
C0332296
prior treatment with any cdk 4/6 inhibitor.
Beschrijving

CDK4 Inhibitor | CDK6 Inhibitor

Datatype

boolean

Alias
UMLS CUI [1,1]
C0246957
UMLS CUI [1,2]
C1999216
UMLS CUI [2,1]
C0252132
UMLS CUI [2,2]
C1999216
Terug naar het begin van de pagina

Similar models

Eligibility Breast Neoplasms NCT01740427

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Gender | Recurrent disease Locoregional | Neoplasm Metastasis | Disease Inappropriate Curative treatment
Item
adult women with locoregionally recurrent or metastatic disease not amenable to curative therapy.
boolean
C0001675 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0277556 (UMLS CUI [3,1])
C1947913 (UMLS CUI [3,2])
C0027627 (UMLS CUI [4])
C0012634 (UMLS CUI [5,1])
C1548788 (UMLS CUI [5,2])
C1273390 (UMLS CUI [5,3])
Oestrogen receptor positive breast cancer
Item
confirmed diagnosis of er positive breast cancer
boolean
C2938924 (UMLS CUI [1])
Cancer treatment Systemic Absent | Advanced disease Estrogen receptor positive
Item
no prior systemic anti-cancer therapy for advanced er+ disease.
boolean
C0920425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0679246 (UMLS CUI [2,1])
C0279754 (UMLS CUI [2,2])
Postmenopausal state
Item
postmenopausal women
boolean
C0232970 (UMLS CUI [1])
Measurable Disease | Bone Disease only
Item
measurable disease as per response evaluation criterion in solid tumors [recist] or bone-only disease
boolean
C1513041 (UMLS CUI [1])
C0005940 (UMLS CUI [2,1])
C0205171 (UMLS CUI [2,2])
ECOG performance status
Item
eastern cooperative oncology group [ecog] 0-2
boolean
C1520224 (UMLS CUI [1])
Organ function | Bone Marrow function
Item
adequate organ and marrow function
boolean
C0678852 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
Tumor tissue sample Provide
Item
patient must agree to provide tumor tissue
boolean
C0475358 (UMLS CUI [1,1])
C1999230 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Disease HER2 Positive
Item
confirmed diagnosis of her2 positive disease
boolean
C0012634 (UMLS CUI [1,1])
C2348909 (UMLS CUI [1,2])
Spread Visceral Symptomatic Advanced | At risk Complications Life Threatening
Item
patients with advanced, symptomatic, visceral spread that are at risk of life threatening complication in the short term
boolean
C0332261 (UMLS CUI [1,1])
C0442045 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,3])
C0205179 (UMLS CUI [1,4])
C1444641 (UMLS CUI [2,1])
C0009566 (UMLS CUI [2,2])
C2826244 (UMLS CUI [2,3])
CNS metastases Uncontrolled | CNS metastases Symptomatic
Item
known uncontrolled or symptomatic cns metastases
boolean
C0686377 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0686377 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
Adjuvant therapy Letrozole | Adjuvant therapy Anastrozole | Neoadjuvant Therapy Letrozole | Neoadjuvant Therapy Anastrozole | Treatment completed | Interval Disease Free
Item
prior (neo)adjuvant treatment with letrozole or anastrozole with dfi ≤ 12-months from completion of treatment.
boolean
C0677850 (UMLS CUI [1,1])
C0246421 (UMLS CUI [1,2])
C0677850 (UMLS CUI [2,1])
C0290883 (UMLS CUI [2,2])
C0600558 (UMLS CUI [3,1])
C0246421 (UMLS CUI [3,2])
C0600558 (UMLS CUI [4,1])
C0290883 (UMLS CUI [4,2])
C0580352 (UMLS CUI [5])
C1272706 (UMLS CUI [6,1])
C0012634 (UMLS CUI [6,2])
C0332296 (UMLS CUI [6,3])
CDK4 Inhibitor | CDK6 Inhibitor
Item
prior treatment with any cdk 4/6 inhibitor.
boolean
C0246957 (UMLS CUI [1,1])
C1999216 (UMLS CUI [1,2])
C0252132 (UMLS CUI [2,1])
C1999216 (UMLS CUI [2,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial